Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:14:41 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



News for U:FOLD from 2023-05-04 to 2024-05-03 - 24 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
2024-03-20 07:00U:FOLDNews ReleaseAmicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
2024-03-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
2024-02-28 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
2024-02-15 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
2024-02-08 07:00U:FOLDNews ReleaseAmicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti ¢ „ ¢ (cipaglucosidase alfa-atga) + Opfolda ¢ „ ¢ (miglustat) at the 20th Annual WORLDSymposium ¢ „ ¢
2024-02-01 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium ¢ „ ¢ 2024
2024-01-07 16:01U:FOLDNews ReleaseAmicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
2024-01-03 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-05 06:01U:FOLDNews ReleaseAmicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
2023-11-08 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
2023-11-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
2023-10-27 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2023 ‚  Financial Results on November 8, 2023
2023-10-03 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
2023-10-02 08:20U:FOLDNews ReleaseAmicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
2023-09-28 10:41U:FOLDNews ReleaseAmicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
2023-09-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
2023-08-29 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023
2023-08-21 07:00U:FOLDNews ReleaseAmicus Therapeutics Appoints Simon Harford as Chief Financial Officer
2023-08-15 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval and Launch ‚  of New Pompe Disease Therapy in the United Kingdom
2023-08-08 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
2023-07-31 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Second Quarter 2023 Financial Results on August 8, 2023
2023-06-27 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
2023-05-10 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates